FMP

FMP

Enter

NURO - NeuroMetrix, In...

photo-url-https://images.financialmodelingprep.com/symbol/NURO.png

NeuroMetrix, Inc.

NURO

NASDAQ

NeuroMetrix, Inc., a healthcare company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, China, the Middle East, and Mexico. Its primary marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system, a platform for the performance of nerve conduction studies. The company offers its products to managed care organizations, endocrinologists, podiatrists, and primary care physicians; occupational health, primary care, internal medicine, orthopedic, and hand surgeons; and pain medicine physicians, neurologists, physical medicine and rehabilitation physicians, and neurosurgeons. NeuroMetrix, Inc. was incorporated in 1996 and is headquartered in Woburn, Massachusetts.

3.9 USD

0 (0%)

Historical Prices

From:

To:

We are unable to load the chart at this time.

fmp-logo

About

ceo

Dr. Shai N. Gozani M.D., Ph.D.

sector

Healthcare

industry

Medical - Devices

exchange

NASDAQ

Description

NeuroMetrix, Inc., a healthcare company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, China, the Middle East, and Mexico. Its primary marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system, a platform for the performance of nerve conduction studies. The company offers its products to managed care organizations, endocrinologists, podiatrists, and primary care physician...

CIK

0001289850

ISIN

US6412558800

CUSIP

641255807

Address

4B Gill Street

Phone

781 890 9989

Country

US

Employee

26

IPO Date

Jul 22, 2004

Financial Statement

We are unable to load the chart at this time.

fmp-logo

Earnings

We are unable to load the chart at this time.

fmp-logo

NURO Financial Summary

CIK

0001289850

Exchange

NASDAQ

Industry

Medical - Devices

Sector

Healthcare

CUSIP

641255807

ISIN

US6412558800

Country

US

Price

3.9

Beta

2.3

Volume Avg.

21.82k

Market Cap

7.97M

Shares

-

52-Week

2.66-4.73

DCF

-0.83

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

-0.86

P/B

-

Website

https://www.neurometrix.com

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

Latest NURO News

It looks like there's no news available.

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep